A First Clinical Trial of Exosomes Derived from Human Mesenchymal Stem Cells to Target Autism
Latest Information Update: 24 Apr 2019
At a glance
- Drugs Exosome therapies (Primary)
- Indications Autistic disorder
- Focus Adverse reactions
- Sponsors Stem Cell Medicine
- 24 Apr 2019 New trial record
- 23 Apr 2019 According to a Stem Cell Medicine media release, the company is preparing for first clinical trial this year, which will target autism.